Bhagwan Mahaveer Hospital & Research Center, Jaipur

Consultant in Medical Oncology

• Working in a multi super-specialty hospital
• Patient Counselling
• Treatment planning
• Treatment planning with MDT
• Management of Oncology emergencies
• Clinical research and trials of Biosimilars
• Supportive care of admitted patients
• Chemotherapy administration
• Palliative Care
• procedure : Bone marrow aspiration and biopsy and lumbar puncture
• Teaching of Juniors residents and nurses

Tata Memorial Hospital Mumbai

Senior Registrar in Medical Oncology

• Studied basics and current standards of oncology
• Baseline evaluation with diagnostic and staging workup
• Patient Counselling
• Treatment planning
• Participated in tumor board meeting for treatment planning
• Management of Oncology emergencies
• Participated in Clinical research and trials
• Worked with team of > 60 Medical oncologists
• Supportive care of admitted patients
• Chemotherapy administration
• Palliative Care
• procedure : Bone marrow aspiration and biopsy and lumbar puncture
• Teaching of Juniors

Safdarjung Hospital, New Delhi

Senior Resident in Medical Oncology

• Baseline evaluation with diagnostic and staging workup
• Patient Counselling
• Treatment planning
• Supportive care of admitted patients
• Chemotherapy administration
• Palliative Care
• procedure : Bone marrow aspiration and biopsy and lumbar puncture
• Teaching of Junior residents and UG students

Apex Hospitals, Malviya Nagar Jaipur

Consultant Medical Oncology

• Running a department of Medical Oncology alone
• Working in a multi super-specialty hospital
• Managing patients in collaboration of other specialties and super-specialties
• Baseline evaluation with diagnostic and staging workup
• OPD, Day Care and IPD management
• Managing Cross References
• Patient Counselling
• Treatment planning
• Treatment planning with MDT
• Management of Oncology emergencies
• Clinical research and trials of Biosimilars
• Supportive care of admitted patients
• Chemotherapy administration
• Palliative Care
• procedure : Bone marrow aspiration and biopsy and lumbar puncture
• Teaching of Juniors residents and nurses

• • D.M. Medical Oncology – Tata Memorial Hospital, Mumbai, August 2014 to July 2017
  • M.D. General Medicine – S.N. Medical College , Agra, May 2009 to June 2012
  • M.B.B.S. – S.M.S.Medical College , Jaipur, Rajasthan 2001-2006

DM Medical Oncology

Tata Memorial Hospital , Mumbai

MD General Medicine

S N Medical College, Agra

MBBS

SMS Medical College Jaipur , Internship from July 2006 to June 2007

• • Dr. Sudeep Gupta – Professor medical oncology department, and Director, (CRC) ACTREC. sudeepgupta04@yahoo.com
  • Dr. Shripad D Banavali – Academic director (Dean) Of Tata Memorial Hospital Mumbai. banavali_2000@yahoo.com
  • Dr. NavinKhattry – Professor and BMT Program Coordinator, Department of MedicalOncology and Deputy Director, (CRC) ACTREC at Tata Memorial hospital. nkhattry@gmail.com
  • Dr Kumar Prabhash – Professor and Head Department of at Tata Memorial hospital. kprabhash1@gmail.com
  • Dr S.P. Katariya Head of Department of Medical Oncology, Safdarjung Hospital, New Delhi
  • Dr Sachin Jhawar -CEO Apex Hospitals Malviya Nagar Jaipur. dr.sachinjhawar@apexhospitals.co

• • Letter to Editor : Management of Ovarian Cancer. CRST DOI 10.4103/CRST.CRST_128_19
  • Karpe A, Patil VM , Joshi A, Noronha V, Gupta S, Ramaswamy A , Sahu A , Doshi V , Gupta T, Rath S , Banavali S , Prabhash K . Weekly cisplatin (30-40 mg/m2) as radiosensitizer: Is it high or moderate emetic agent?: Indian J Cancer. 2016 Jul-Sep;53(3):454-456.
  • Patil VM, Noronha V, Joshi A, Ramaswamy A , Gupta S, Sahu A , DoshiV ,Gupta T, Rath S , Banavali S , PrabhashK .Adherence to and Implementation of ASCO Antiemetic Guidelines in Routine Practice in a Tertiary Cancer Center in India: JOncolPract. 2017 Jun;13(6):e574-e581
  • Trial ( awaiting for publication) – “ To study the Effect of structured teaching module on Capecitabine induced Hand –Foot syndrome in patients with Colorectal Cancer at Tertiary Care Centre.” A prospective randomized Control Trial.
  • VikasOstwal, Tarachand Gupta , Supriya Chopra , Sherly Lewis , Mahesh Goel, Shraddha Patkar , Nitin Shetty , AnantRamaswamy .Tolerance and adverse event profile with Sorafenib in Indian patients with advanced hepatocellular carcinoma: South Asian J Cancer 2017;6:144-6
  • AnantRamaswamy; RushabhKoathari; Ashwin Desouza; Tarachand Gupta; Sandeep Bairwa; Akhil Kapoor; Amit Kumar; Pradeep Ventrapati; MuktaRamadwar; SarikaMandavkar; Nita Chavan; AvanishSaklani; VIKAS OSTWAL. Adjuvant chemotherapy in stage II – III operated colon cancer patients from a non-trial cohort in a low colon cancer prevalence country and use of modified CAPOX. South Asian J Cancer
    Jul-Sep 2019;8(3):160-165.
    doi: 10.4103/sajc.sajc_176_18
  • Thesis in M.D. “ Evaluation of various ischaemic end points response in patient subjects for stress test and its correlation with various risk factors.”
  • Paper presentation on “ A study to compare the role of N-Acetyl Cysteine and combination of N-Acetyl Cysteine with Taurine in proteinuria in Diabetes mellitus” in UPDACON 2010 Jhansi
  • Poster presentation titled “Association of Lipoprotein (A) in Patients of Acute Myocardial Infarction” in IACM Patna 2011
  • Attended the ECG learning course, conducted by Indian Society of Electro cardiology on 6 th august 2011.

• • 5 th rank in all India level entrance test of Tata Memorial Hospital for D.M. Medical oncology 2014
  • Only candidate selected in July 2014 for PhD in medical oncology at AIIMS
  • 771st Rank in all India entrance test for Medical post-graduation courses 2009
  • 30 th Rank in Rajasthan Pre Medical Test 2001
  • Gold medal in intracollege Carom championship in Mixed double category in 2004

• • Organizing secretory of 2 days National webinar on genitourinary cancers GU Conundrum 2020, 24th and 25th September.
  • Panelist in Session of Small Cell Lung Cancer in webinar of OncoWebex2020on 30th September 2020
  • Chairperson in Session ” Screening and early lung cancer ” in lung cancer master class 19th July 2020
  • Panelist in webinar of Breast Cancer Chakravyuh – Breaking Barriers In session on Her2 Neu MBC
  • Chairperson in webinar of Best clinical oncology symposium 10th June 2020
  • Panelist in “Update in Lung Cancer YER 2019”, Mumbai 20-22 December 2019
  • Panelist in IBCC 2019 Jaipur in session on Multimodality treatment of LABC
  • Moderator in Jaipur CME on lymphoma 19th July 2019 .
  • Speaker : Abstract of Phase III Trial of Rd Followed by R vs Continuous Rd in Intermediate-Fit Elderly
  • Patients With Newly Diagnosed Multiple Myeloma in Hematology update 2019″ Jaipur. 05-01-2019
  • Panelist in “Update in Lung Cancer YER 2018”, Mumbai 15th and 16th December 2018
  • Chairperson in session 3of Lung Cancer in “UAE Cancer congress 2018” , Dubai 11th to 13th October 2018
  • Quiz Master and Panelist in “ IBCC 2018” Jaipur.

• • Head And Neck : A Phase II Clinical Study to evaluate the efficacy and safety of NRC-2694-A in patients with Recurrent Head and Neck Squamous cell Carcinoma.
  • RCC-A Randomized, Open Label, Multi-Center, Two-Treatment, Two-Period, Two-Sequence, Two-Way Crossover, Multiple Dose, Steady-State Bioequivalence (BE) Study of Pazopanib HCL 200mg Tablets at a Dose of 800mg (4 * 200 mg tablets) of Lotus Pharmaceutical Co., Ltd., Taiwan with VOTRIENT® (Pazopanib HCL 200mg) Tablets at a Dose of 800 mg (4 * 200 mg tablets) of Novartis Pharmaceuticals Corporation, USA in Subjects with Advanced Renal Cell Carcinoma Under Fasting Condition
  • Ongoing Biosimilar Trial (Recruitment Completed) :Randomized, Assessor- Blind, Multicentre,Parellel Group, Two Arms, Clinical Study to Assess the Efficacy, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety of Rituximab ( Test Product, Zydus) in comparision with Rituximab( Reference product, Roche/Genentech) in Patients with Diffuse Large B Cell Lymphoma (DLBCL).
  • Ongoing Biosimilar Trial (Recruitment Completed) : A Prospective,Randomized, Multicenter Comparative, Open label ,Parellel Study to evaluate the Efficacy, Safety and Pharmacokinetics, of Test-Trastuzumab Emtansine ( ZRC3256;Cadila Healthcare Ltd) and Reference- Trastuzumab Emtansine(Kadcyla, Roche Products (India)Pvt.Ltd) in HER 2- Positive Metastatic Breast Cancer Patients